<DOC>
	<DOCNO>NCT01105793</DOCNO>
	<brief_summary>The purpose study determine safety topical FP1198 treatment moderate severe cyclic breast pain ( cyclic mastalgia ) examine clinical activity FP1198 .</brief_summary>
	<brief_title>An Open-Label , MultiCenter Evaluation Use Topically Administered FP1198 Subjects With Pain Associated With Cyclic Mastalgia</brief_title>
	<detailed_description />
	<mesh_term>Mastodynia</mesh_term>
	<mesh_term>Danazol</mesh_term>
	<criteria>menstruate female least 18 year age BMI le 30 moderate severe breast pain associate menstrual cycle good general health pregnant within last 6 month take last 3 month currently take hormonal contraception history malignancy currently treat cancer breast genital organ breast implant breast reduction surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>cyclic mastalgia</keyword>
	<keyword>cyclic breast pain</keyword>
	<keyword>fibrocystic breast disease</keyword>
</DOC>